Literature DB >> 2545405

Supravital dithizone staining in the isolation of human and rat pancreatic islets.

W A Hansen1, M R Christie, R Kahn, A Norgaard, I Abel, A M Petersen, D W Jorgensen, S Baekkeskov, J H Nielsen, A Lernmark.   

Abstract

Dithizone, a zinc chelating agent, is known to selectively stain the islets of Langerhans in the pancreas. In the present study, we have used this stain to aid the identification of islets in material obtained by collagenase digestion of human pancreas. Islets were shown to rapidly and reversibly stain red on incubation with dithizone solution. Tissue selected on the basis of dithizone staining was shown to contain insulin-positive cells and to accumulate insulin in the medium during a subsequent period in tissue culture. Experiments with rat islets indicated that the dithizone treatment had no effect on insulin release in tissue culture, on acute responses to stimulatory glucose concentrations or on the insulin content of cells. These results suggest that dithizone staining can assist in the identification of islets from the human pancreas and may prove to be a useful tool in developing techniques for the large scale isolation of functionally intact human islets.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2545405

Source DB:  PubMed          Journal:  Diabetes Res        ISSN: 0265-5985


  12 in total

1.  [In vitro and in vivo studies of isolation, transplantation and function of Langerhans islets in the swine].

Authors:  U J Hesse; J Danis; J Weyer; G Meyer; S Saad
Journal:  Langenbecks Arch Chir       Date:  1990

2.  Evidence for recognition of novel islet T cell antigens by granule-specific T cell lines from new onset type 1 diabetic patients.

Authors:  T I Tree; D O'Byrne; J M Tremble; W M MacFarlane; K Haskins; R F James; K Docherty; J C Hutton; J P Banga
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

3.  In vitro differentiation of human pancreatic duct-derived PANC-1 cells into β-cell phenotype using Tinospora cordifolia.

Authors:  Hemangee Damame; Sheetalnath Rooge; Rahul Patil; Chandramukhi Garad; Akalpita Arvindekar
Journal:  In Vitro Cell Dev Biol Anim       Date:  2022-06-06       Impact factor: 2.416

4.  Murine pancreatic ductal adenocarcinoma produced by in vitro transduction of polyoma middle T oncogene into the islets of Langerhans.

Authors:  T Yoshida; D Hanahan
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

Review 5.  Acute and chronic animal models for the evaluation of anti-diabetic agents.

Authors:  Suresh Kumar; Rajeshwar Singh; Neeru Vasudeva; Sunil Sharma
Journal:  Cardiovasc Diabetol       Date:  2012-01-19       Impact factor: 9.951

6.  Impact of streptozotocin on altering normal glucose homeostasis during insulin testing in diabetic rats compared to normoglycemic rats.

Authors:  Nidal A Qinna; Adnan A Badwan
Journal:  Drug Des Devel Ther       Date:  2015-05-05       Impact factor: 4.162

Review 7.  The Flaws and Future of Islet Volume Measurements.

Authors:  Han-Hung Huang; Stephen Harrington; Lisa Stehno-Bittel
Journal:  Cell Transplant       Date:  2018-06-28       Impact factor: 4.064

8.  Mesobiliverdin IXα Enhances Rat Pancreatic Islet Yield and Function.

Authors:  Taihei Ito; Dong Chen; Cheng-Wei Tom Chang; Takashi Kenmochi; Tomonori Saito; Satoshi Suzuki; Jon Y Takemoto
Journal:  Front Pharmacol       Date:  2013-04-23       Impact factor: 5.810

Review 9.  Current status and patent prospective of animal models in diabetic research.

Authors:  Radhey S Dhuria; Gurpreet Singh; Anudeep Kaur; Ramandeep Kaur; Tanurajvir Kaur
Journal:  Adv Biomed Res       Date:  2015-05-29

10.  APT070 (mirococept), a membrane-localizing C3 convertase inhibitor, attenuates early human islet allograft damage in vitro and in vivo in a humanized mouse model.

Authors:  Fang Xiao; Liang Ma; Min Zhao; Richard A Smith; Guocai Huang; Peter M Jones; Shanta Persaud; Attilio Pingitore; Anthony Dorling; Robert Lechler; Giovanna Lombardi
Journal:  Br J Pharmacol       Date:  2016-01-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.